Patents by Inventor Stanley Shackney

Stanley Shackney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composite Profiles of Cell Antigens and Target Signal Transduction Proteins for Analysis and Clinical Management of Hematologic Cancers
    Publication number: 20100261204
    Abstract: The present invention is directed to methods for establishing a composite marker profile for a sample derived from an individual suspected having a neoplastic condition. A composite marker profile of the invention allows for identification of prognostically and therapeutically relevant subgroups of neoplastic conditions and prediction of the clinical course of an individual. The methods of the invention provide tools useful in choosing a therapy for an individual afflicted with a neoplastic condition, including methods for assigning a risk group, methods of predicting an increased risk of relapse, methods of predicting an increased risk of developing secondary complications, methods of choosing a therapy for an individual, methods of determining the efficacy of a therapy in an individual, and methods of determining the prognosis for an individual.
    Type: Application
    Filed: January 29, 2010
    Publication date: October 14, 2010
    Applicant: Beckman Coulter, Inc.
    Inventors: Charles GOOLSBY, T. Vincent Shankey, David Hedley, James Jacobberger, Stanley Shackney
  • Composite profiles of cell antigens and target signal transduction proteins for analysis and clinical management of hematologic cancers
    Publication number: 20070105165
    Abstract: The present invention is directed to methods for establishing a composite marker profile for a sample derived from an individual suspected having a neoplastic condition. A composite marker profile of the invention allows for identification of prognostically and therapeutically relevant subgroups of neoplastic conditions and prediction of the clinical course of an individual. The methods of the invention provide tools useful in choosing a therapy for an individual afflicted with a neoplastic condition, including methods for assigning a risk group, methods of predicting an increased risk of relapse, methods of predicting an increased risk of developing secondary complications, methods of choosing a therapy for an individual, methods of determining the efficacy of a therapy in an individual, and methods of determining the prognosis for an individual.
    Type: Application
    Filed: November 4, 2005
    Publication date: May 10, 2007
    Inventors: Charles Goolsby, T. Shankey, David Hedley, James Jacobberger, Stanley Shackney